Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | P4HTM | Q9NXG6 | 3/20 | 0.61 |
| ▸ | CCR1 | P32246 | 3/20 | 0.61 |
| ▸ | CCR5 | P51681 | 3/20 | 0.61 |
| ▸ | CCR8 | P51685 | 3/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | METAP1 | P53582 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.61 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 3/20 | 0.58 |
| ▸ | NPC1 | O15118 | 3/20 | 0.58 |
| ▸ | RAB9A | P51151 | 3/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30516908 | 1.00 | KDM4E (0.61) | KDM4ELMNAP4HTMCCR1CCR5 | |
| SCHEMBL29705476 | 1.00 | KDM4E (0.61) | KDM4ELMNAP4HTMCCR1CCR5 | |
| SCHEMBL1070654 | 0.83 | CCR1 (0.46) | KDM4ELMNAP4HTMCCR1CCR5 | |
| SCHEMBL30958843 | 0.83 | CCR1 (0.46) | KDM4ELMNAP4HTMCCR1CCR5 | |
| SCHEMBL24302699 | 0.80 | ALDH1A1 (0.52) | KDM4ELMNAP4HTMCCR1CCR5 | |
| Dipyridyl SCHEMBL27648895 | 0.79 | KDM4E (0.70) | KDM4ELMNAP4HTMCCR1CCR5 | |
| Dipyridyl SCHEMBL28330098 | 0.79 | KDM4E (0.70) | KDM4ELMNAP4HTMCCR1CCR5 | |
| SCHEMBL163378 | 0.79 | KDM4E (0.78) | KDM4ELMNAP4HTMCCR1CCR5 | |
| Dipyridyl SCHEMBL27651116 | 0.78 | KDM4E (0.88) | KDM4ELMNAP4HTMCCR1CCR5 | |
| Dipyridyl SCHEMBL29907716 | 0.78 | KDM4E (1.00) | KDM4ELMNAP4HTMCCR1CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116536719-A | Identification code for lead frame and silver plating process thereof | 安徽立德半导体材料有限公司 | 2023-08-04 | — | — | CN | claimed |
| CN-116536719-A | Identification code for lead frame and silver plating process thereof | 安徽立德半导体材料有限公司 | 2023-08-04 | — | — | CN | disclosed |
| US-11377436-B2 | EAAT2 enhancing molecules | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2022-07-05 | — | — | US | disclosed |
| US-20210163440-A1 | EAAT2 ENHANCING MOLECULES | BRIGHAM & WOMENS HOSPITAL INC (US) | 2021-06-03 | — | — | US | disclosed |
| US-10203333-B2 | Electronically neutral metal complexes as biological labels | RUBIPY SCIENTIFIC, INC. (CA) | 2019-02-12 | — | — | US | disclosed |
| WO-2019014460-A1 | EAAT2 ENHANCING MOLECULES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2019-01-17 | — | — | WO | disclosed |
| US-20160146826-A1 | Electronically Neutral Metal Complexes As Biological Labels | HUNAN SANSURE ACCUCISE BIOTECHNOLOGY CO., LTD. (CN) | 2016-05-26 | — | — | US | disclosed |
| US-20160146826-A1 | Electronically Neutral Metal Complexes As Biological Labels | HUNAN SANSURE ACCUCISE BIOTECHNOLOGY CO., LTD. (CN) | 2016-05-26 | — | — | US | disclosed |
| WO-2014203067-A1 | ELECTRONICALLY NEUTRAL METAL COMPLEXES AS BIOLOGICAL LABELS | RUBIPY SCIENTIFIC, INC. (CA) | 2014-12-24 | — | — | WO | disclosed |
| EP-1702919-B1 | NOVEL 2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVE | MSD KK (JP) | 2012-05-30 | — | — | EP | disclosed |
| US-7728025-B2 | 2-heteroaryl-substituted benzimidazole derivative | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20080070928-A1 | Novel 2-Heteroaryl-Substituted Benzimidazole Derivative | MSD K.K. (JP) | 2008-03-20 | — | — | US | disclosed |
| EP-1824839-A2 | SUBSTITUTED BIARYL ANALOGUES | NEUROGEN CORPORATION (US) | 2007-08-29 | — | — | EP | disclosed |
| EP-1702919-A1 | NOVEL 2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2006-09-20 | — | — | EP | disclosed |
| WO-2006071538-A2 | SUBSTITUTED BIARYL ANALOGUES | NEUROGEN CORPORATION (US) | 2006-07-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210163440-A1 | EAAT2 ENHANCING MOLECULES | SLC1A2, SLC1A1, SLC1A3 | KDM4E 3651/4885LMNA 4504/4885P4HTM 1491/4885 |
| US-10203333-B2 | Electronically neutral metal complexes as biological labels | MB, MCU, LETM1 | KDM4E 2185/4885LMNA 532/4885P4HTM 2681/4885 |
| US-20080070928-A1 | Novel 2-Heteroaryl-Substituted Benzimidazole Derivative | GCK, GCKR, HK1 | KDM4E 2940/4885LMNA 3434/4885P4HTM 4396/4885 |
| US-11377436-B2 | EAAT2 enhancing molecules | SLC1A2, SLC1A1, SLC1A3 | KDM4E 3651/4885LMNA 4504/4885P4HTM 1491/4885 |
| US-20160146826-A1 | Electronically Neutral Metal Complexes As Biological Labels | MB, MCU, LETM1 | KDM4E 2185/4885LMNA 532/4885P4HTM 2681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.